NEW YORK, October 05, 2012 – Stockmarketnation.com, one of the leaders in providing stock updates on U.S. stock, markets are announcing valuable information on Sprint Nextel Corporation, Netflix, MetroPCS Communications, Vringo, Cell Therapeutics.
After Deutsche Telekom announced a deal to merge its T-Mobile USA unit with MetroPCS Communications Inc(NYSE:PCS), Sprint Nextel Corporation(NYSE:S) is reported to be evaluating making a bid for the company, that it had once rejected earlier this year..
Sprint Nextel had abandoned a plan to acquire MetroPCS in February as it felt that it was too costly.Will Sprint Continue To Hit New Highs? Find Out Here http://stockmarketnation.com/?company=S
However there has been a dramatic change since then in Sprint's fortunes with its shares having more than doubled since February, giving it more leveraging power now in making an acquisition.
According to a report by Bloomberg, Sprint's Dan Hesse and his board are expected to meet again soon to consider making a bid for Metro. Hesse has earlier said that he expected Sprint to be part of a consolidation process in the telecom sector.Netflix, Inc.(NASDAQ:NFLX), which provides live video content and DVDs for rentals, will soon be releasing its original series, `House of Cards' on Feb 1, 2013.
The company announced the premiere date on Thursday and it is part of the company's plans to provide its subscribers with original programming content.
Has NFLX Found The Bottom and Ready To Hit $100 Soon? Don’t Miss Our Special Report Here http://stockmarketnation.com/?company=NFLX
All 13 episodes will be immediately available to Netflix members in North America, the United Kingdom, Ireland, Latin America and Scandinavia.
A court order which dismissed a Google petition to throw out a patent lawsuit by Vringo sent the latter's shares soaring 23 percent to $5.27 in afternoon trades.The lawsuit filed by Vringo, Inc.(NYSEAMEX:VRNG) against Google and its partners - AOL IAC, Target and Gannett Co - deals with two patents originally belonging to search engine Lycos. Vringo acquired them when it bought I/P Engine in July.
Will VRNG Hit $10 This Month? Get Special Report Here http://stockmarketnation.com/?company=VRNG
Cell Therapeutics Inc(NASDAQ:CTIC) shares plunged 24.26% to $1.54 after the company today announced the pricing of an underwritten public offering of 60,000 shares of its Series 17 Preferred Stock, offered at a price to the public of $1,000 per share of Series 17 Preferred Stock (the Offering). Each share of Series 17 Preferred Stock is convertible at the option of the holder, at any time, into approximately 714 shares of common stock at a conversion price of $1.40 per share of common stock, for a total of approximately 42.9 million shares of common stock. The shares of Series 17 Preferred Stock will automatically convert into shares of common stock in certain circumstances.
Will ABR Bounce Back After Today’s Slump? Find Out Here http://stockmarketnation.com/?company=CTIC
About StockMarketNation.comStockMarketNation team is engaged in providing valuable and updated news information on U.S. stocks on a regular basis. StockMarketNation's instant stock news on Major Gainers, Hot Stocks and various other stocks, guides investors in making the wise stock market investments decision. To Get Instant updates in the inbox, readers are advised to sign up for free at StockMarketNation.com.
Disclaimer:The assembled information disseminated by StockMarketNation is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. StockMarketNation does expect that investors will buy and sell securities based on information assembled and presented in phd-trading.com. PLEASE always do your own due diligence, and consult your financial advisor.